Fridman, US
Adam Fridman, Northbrook, IL US
Patent application number | Description | Published |
---|---|---|
20120296740 | SYSTEM AND METHODS FOR SELECTIVELY IMPLEMENTING ENDORSEMENTS AND VERIFYING ENDORSEMENT COMPLIANCE - A system and method of implementing endorsements on mobile objects such that brands can recruit advertisers to promote their products and services in exchange for a reward. The method also allows for verification of compliance with the endorsement requirements submitted by the brands. Furthermore, the methods of the present invention allow for advertisers to solicit or approach brands whose services they want to promote. | 11-22-2012 |
Alexander Fridman, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20110136162 | Compositions and Methods for Functionalized Patterning of Tissue Engineering Substrates Including Bioprinting Cell-Laden Constructs for Multicompartment Tissue Chambers - The present invention relates to microfluidic systems and methods for monitoring or detecting a change in a characteristic of an input substance. Specifically, the invention relates to a model for in vitro pharmacokinetic study and other pharmaceutical applications, as well as other uses including computing, sensing, filtration, detoxification, production of chemicals and biomolecules, testing cell/tissue behavior, toxicology, drug metabolism, drug screening, drug discovery, and implantation into a subject. The present invention also relates to systems and methods of a microplasm functionalized surface patterning of a substrate. The present invention represents an improvement over existing plasma systems used to modify the surface of a substrate, as the present invention creates surface patterning without the use of a mask, stamp or a chemical treatment. | 06-09-2011 |
20120090985 | NON-EQUILIBRIUM GLIDING ARC PLASMA SYSTEM FOR CO2 DISSOCIATION - A reactor for dissociating carbon dioxide, and associated processes and systems, are described herein. In one example, a reactor is provided that is configured to use non-equilibrium gliding arc discharge plasma. In another example, the reactor uses a vortex flow pattern. A diaphragm may be used at the output of the reactor to control the vortex flow pattern. In some examples, the reactor may be configured to have varying upper and lower chamber sizes. | 04-19-2012 |
20120100524 | TUBULAR FLOATING ELECTRODE DIELECTRIC BARRIER DISCHARGE FOR APPLICATIONS IN STERILIZATION AND TISSUE BONDING - Disclosed is a device and method for contacting a biological substrate. A non-thermal plasma device delivers a non-thermal plasma discharge using a dielectric conduit, an igniter electrode and a RF electrode. The dielectric conduit fluidicly communicates a gas therethrough and an igniter electrode ionizes at least a portion of the gas. The RF electrode, disposed circumferentially proximate to the exterior of the dielectric conduit, generates non-thermal plasma from the ionized gas. The non-thermal plasma is discharged from the dielectric conduit and contacts a biological substrate. The non-thermal plasma discharge may be suitable for tissue bonding and sterilization applications. | 04-26-2012 |
20120135390 | PLASMA TREATMENT FOR GROWTH FACTOR RELEASE FROM CELLS AND TISSUES - Aspects of the present invention are related to methods comprising contacting an endothelial cell in an endothelial cell population with a non-thermal plasma to release an angiogenic growth factor. The released angiogenic growth factor may induce endothelial cell proliferation. In certain embodiments, the angiogenic growth factor is fibroblast growth factor-2. Preferably, the non-thermal plasma may be an atmospheric pressure dielectric barrier discharge. Additional aspects of the present invention are directed to methods for treating a disease comprising promoting angiogenesis by contacting an endothelial cell in a endothelial cell population with a non-thermal plasma to release an angiogenic growth factor. The angiogenic growth factor may induce endothelial cell proliferation. Further aspects of the present invention are directed to methods for treating a disease comprising inhibiting angiogenesis by contacting an endothelial cell in a endothelial cell population with a non-thermal plasma to reduce the number of endothelial cells in the population. | 05-31-2012 |
20120156091 | METHODS AND DEVICES FOR TREATING SURFACES WITH SURFACE PLASMA` - Methods and devices for treating surfaces of objects using a non-thermal plasma are disclosed herein. The non-thermal plasma is generated through the use of an apparatus configured to generate a non-thermal plasma on its surface. The apparatus is comprised of a substrate that contains one or more electrodes of different polarity. The electrodes are placed within a layer of the substrate acting as a dielectric layer. The apparatus may also have additional layers to contain the dielectric layer. When an appropriate potential, being either an alternating current or pulsed high voltage potential, is applied and removed from the one or more electrodes, the gas on at least one surface of the apparatus becomes ionized and forms a non-thermal plasma. The electrodes can be configured to be of various shapes and sizes to modify or tune the plasma. | 06-21-2012 |
20120253265 | METHODS AND DEVICES FOR THE TREATMENT AND PREVENTION OF MALIGNANCY IN ENTERIC DISEASES USING NON-THERMAL PLASMA - Non-thermal plasma is a partly ionized gas, which can be generated by a high-voltage electric field at a low pressure. Disclosed herein are apparatuses and methods for treating an enteric disease in vivo using non-thermal plasma. The disclosed apparatuses have a first conduit comprising a lumen and a tip; a first electrode disposed within the lumen of the first conduit; a second electrode comprised of a metal conduit disposed within the first conduit; an insulator disposed within the lumen of the first conduit, the insulator configured to electrically insulate the first electrode from the second electrode; and a gas channel disposed between the outer surface of the metal conduit and the inner surface of the first conduit, the gas channel being capable of feeding a gas from a gas source to the tip, wherein when the potential is applied, the gas is ionized to produce the non-thermal plasma. | 10-04-2012 |
20120296265 | APPARATUS FOR ATMOSPHERIC PRESSURE PIN-TO-HOLE SPARK DISCHARGE AND USES THEREOF - Disclosed herein are atmospheric pressure pin-to-hole pulsed spark discharge devices and methods for creating plasma. The devices include a conduit for fluidically communicating a gas, a plasma, or both, therethrough, portion of the conduit capable of being connected to a gas supply, and a second portion of the conduit capable of emitting a plasma; a positive electrode comprising a sharp tip; and a ground plate electrode. Disclosed are methods for treating a skin ulcer using non-thermal plasma include flowing a gas through a cold spark discharge zone simultaneously with the creation of a pulsed spark discharge to give rise to a non-thermal plasma emitted from a conduit, the non-thermal plasma comprising NO; and contacting a skin ulcer with said non-thermal plasma for sufficient time and intensity to give rise to treatment of the skin ulcer. | 11-22-2012 |
20130310731 | METHODS FOR NON-THERMAL APPLICATIONS OF GAS PLASMA TO LIVING TISSUE - Method for the non-thermal treatment of human or animal tissue with high-voltage electrical discharge plasma is disclosed. The disclosed method employs current through plasma and through tissue not for the purpose of heating the tissue, but instead to maintain the plasma proximate to the tissue being treated. Also disclosed is a method of limiting the current through plasma and through tissue to minimize tissue heating by placement of an insulator or semiconductor between an electrode and tissue resulting in generation of a high-voltage discharge similar to a dielectric barrier discharge. The disclosed non-thermal plasma treatment can be employed to promote coagulation of blood, sterilization, disinfection, re-connection of tissue, and treatment of tissue disorders without causing significant thermal tissue damage. | 11-21-2013 |
20130330229 | PLASMA SYSTEM FOR AIR STERILIZATION - A method for decontaminating bioaerosol with high concentrations of bacterial, viral, spore and other airborne microorganisms or biologic contaminants in flight at high flow rates. A plasma screen created across the flow of air contaminated with airborne biologic agents renders contaminants non-culturable within milliseconds. The technology may cooperate with heating, ventilation, and air conditioning (HVAC) systems. It may be particularly beneficial in preventing bioterrorism and the spread of toxic or infectious agents, containing airborne pandemic threats such as avian flu, sterilizing spaces such as hospitals, pharmaceutical plants and manufacturing facilities, treating exhaust ventilation streams, minimizing biological environmental pollutants in industrial settings, improving general air quality, preventing sick building syndrome. | 12-12-2013 |
20140021035 | HIGH POWER NON-THERMAL PLASMA SYSTEM FOR INDUSTRIAL APPLICATIONS - Methods of increasing the total power of non-thermal plasma power systems are described. Various embodiments of the present invention provide non-thermal plasma reactor assemblies and methods of operating said assemblies, each assembly comprising: (a) at least two non-thermal plasma reactors, each reactor comprising at least one inlet circumferential gas flow inlet apparatus, an electrode, and a flow restricted exit portal, said reactor configured to eject a jet of non-thermal plasma external to said reactor; (b) said at least two non-thermal plasma reactors configured to work in tandem with one another such that a first reactor electrode can be maintained at a high voltage electric potential relative to a second reactor electrode, said first and second reactor electrodes forming an electrode pair able to maintain a non-thermal plasma discharge between the first and second reactor electrodes. | 01-23-2014 |
20140124357 | PRE-TREATING WATER WITH NON-THERMAL PLASMA - The present invention consists of a method of pre-treatment of adulterated water for distillation, including adulterated water produced during hydraulic fracturing (“fracking”) of shale rock during natural gas drilling. In particular, the invention is directed to a method of treating adulterated water, said adulterated water having an initial level of bicarbonate ion in a range of about 250 ppm to about 5000 ppm and an initial level of calcium ion in a range of about 500 ppm to about 50,000 ppm, said method comprising contacting the adulterated water with a non-thermal arc discharge plasma to produce plasma treated water having a level of bicarbonate ion of less than about 100 ppm. Optionally, the plasma treated water may be further distilled. | 05-08-2014 |
20140311891 | TUBULAR FLOATING ELECTRODE DIELECTRIC BARRIER DISCHARGE FOR APPLICATIONS IN STERILIZATION AND TISSUE BONDING - Disclosed is a device and method for contacting a biological substrate. A non-thermal plasma device delivers a non-thermal plasma discharge using a dielectric conduit, an igniter electrode and a RF electrode. The dielectric conduit fluidicly communicates a gas therethrough and an igniter electrode ionizes at least a portion of the gas. The RF electrode, disposed circumferentially proximate to the exterior of the dielectric conduit, generates non-thermal plasma from the ionized gas. The non-thermal plasma is discharged from the dielectric conduit and contacts a biological substrate. The non-thermal plasma discharge may be suitable for tissue bonding and sterilization applications. | 10-23-2014 |
20140314621 | METHODS AND DEVICES FOR TREATING SURFACES WITH SURFACE PLASMA - Methods and devices for treating surfaces of objects using a non-thermal plasma are disclosed herein. The non-thermal plasma is generated through the use of an apparatus configured to generate a non-thermal plasma on its surface. The apparatus is comprised of a substrate that contains one or more electrodes of different polarity. The electrodes are placed within a layer of the substrate acting as a dielectric layer. The apparatus may also have additional layers to contain the dielectric layer. When an appropriate potential, being either an alternating current or pulsed high voltage potential, is applied and removed from the one or more electrodes, the gas on at least one surface of the apparatus becomes ionized and forms a non-thermal plasma. The electrodes can be configured to be of various shapes and sizes to modify or tune the plasma. | 10-23-2014 |
20150038584 | MATERIALS FOR DISINFECTION PRODUCED BY NON-THERMAL PLASMA - Aspects of the present subject matter are directed to a method comprising contacting an fluid, optionally containing an added organic material, with a non-thermal plasma to form a disinfection composition, wherein the disinfection composition is a liquid, and contacting a surface with the disinfection composition, wherein the surface is at least partially disinfected upon contact with the disinfection composition. Additional aspects of the present subject matter are directed to a method comprising forming a disinfection composition by contacting an organic material with a non-thermal plasma, wherein the disinfection composition is a liquid. A further aspect of the present subject matter is directed to a disinfection composition comprising an organic material contacted by a non-thermal plasma, wherein the disinfection composition is a liquid. | 02-05-2015 |
20150141986 | NANO DISCHARGES IN LIQUIDS - The present invention is direct to a nano-probe corona tool and uses thereof A nano-probe corona tool is disclosed having a tip with a diameter in the nano-scale, typically around 100 nm. The nano-probe corona tool is constructed of electrically conductive material. On the other end of the tool, a pulsed voltage source outputs a pulsed voltage to generate a pulsed electrical potential at the tip. The pulsed electrical potential at the tip causes a plasma discharge corona to occur. Uses of the corona discharge include, but are not limited to, optical emission spectroscopy, in the enhancement of deposition of coatings and nanoscale welding, e.g., nanotube or nanowires to a contact pad and welding two nanowires together, and in nanoscale surgery. For example, a nano-probe comprising CNTs may be inserted into cell membranes. The resulting corona discharge may be used to destroy tumors within the cell. | 05-21-2015 |
20150274554 | FLUID TREATMENT USING PLASMA TECHNOLOGY - The invention is directed to apparatus for treating water by exposing the water to a pulsed plasma discharge. The pulsed plasma discharge is generated using a suitable electrode configuration to generate the plasma discharge in the fluid. Apparatus useful in the method may include a vessel, at least two electrodes for generating a plasma discharge in water, and a flow inlet and a flow outlet to allow water to be passed through the vessel. Also described is an in-line water treatment, where a pulsed plasma discharge is used in a pipe carrying moving water. Plasma based fluid treatment system may have many advantages in comparison to other treatment methods, such as very minimal maintenance, low operating power, and minimal pressure loss through the device. | 10-01-2015 |
20150307350 | HIGH POWER NON-THERMAL PLASMA SYSTEM FOR INDUSTRIAL APPLICATIONS - Methods of increasing the total power of non-thermal plasma power systems are described. Various embodiments of the present invention provide non-thermal plasma reactor assemblies and methods of operating said assemblies, each assembly comprising: (a) at least two non-thermal plasma reactors, each reactor comprising at least one inlet circumferential gas flow inlet apparatus, an electrode, and a flow restricted exit portal, said reactor configured to eject a jet of non-thermal plasma external to said reactor; (b) said at least two non-thermal plasma reactors configured to work in tandem with one another such that a first reactor electrode can be maintained at a high voltage electric potential relative to a second reactor electrode, said first and second reactor electrodes forming an electrode pair able to maintain a non-thermal plasma discharge between the first and second reactor electrodes. | 10-29-2015 |
20150375193 | PLASMA DISSOCIATION OF HYDROGEN SULFIDE IN THE PRESENCE OF OXYGEN - Methods of producing hydrogen and sulfur from the destruction of hydrogen sulfide are provided, each method comprising subjecting hydrogen sulfide (H | 12-31-2015 |
Alexandra Fridman, Ashland, MA US
Patent application number | Description | Published |
---|---|---|
20090319922 | Non-Bypassable Disclosures in Electronic Transactions - Methods, software, and systems for ensuring that one or more pieces of information are presented as a “non-bypassable” manner and can be viewed as intended during an electronic transaction. For instance, where a required disclosure is provided in a pop-up window, it may be provided that the party receiving the disclosure may not complete the application until it is shown that the pop-up window content has fully loaded and thus available to the consumer to review as intended. The pop-up window content may itself include an instruction for determining when the content has been fully loaded. Upon the content being fully loaded, the pop-up window may send a call to the parent window indicating that the content has been fully loaded. In response to the call, the parent window may allow the application process to continue or complete. According to further aspects, it may be determined whether the consumer's computer Internet browser is enabled for use with the call language (for example, JAVASCRIPT). | 12-24-2009 |
Arkady Fridman, Twain Harte, CA US
Patent application number | Description | Published |
---|---|---|
20120136781 | REAL-TIME PAYMENTS THROUGH FINANCIAL INSTITUTION - A payment provider uses bank rails to enable a bank customer to send real-time payments through the bank site by simply entering a recipient identifier, such as an email address or mobile number. The bank has an account with the payment provider. Thus, when the customer sends a payment through the bank, the payment provider transmits the payment to the recipient through the bank's payment provider account. The bank debits the amount from the user's bank account or from a third party, in which case the bank makes a payment to the third party. The sender does not have to have an account with the payment provider, just an account with the bank. | 05-31-2012 |
20130080325 | DEPOSITING AND WITHDRAWING FUNDS - A user without Internet access or a bank account can fund an online payment provider account by depositing cash or voucher from a third party into a machine or with a person, and entering an account identifier, such as an email or phone number. The user can receive cash through the online payment provider by logging into an account through a machine, entering the amount of cash requested, and receiving a voucher. The user can then insert the voucher into a cash dispensing machine or present the voucher to a person to redeem the voucher for cash or redeem the voucher for store merchandise. | 03-28-2013 |
20150278782 | DEPOSITING AND WITHDRAWING FUNDS - A user without Internet access or a bank account can fund an online payment provider account by depositing cash or voucher from a third party into a machine or with a person, and entering an account identifier, such as an email or phone number. The user can receive cash through the online payment provider by logging into an account through a machine, entering the amount of cash requested, and receiving a voucher. The user can then insert the voucher into a cash dispensing machine or present the voucher to a person to redeem the voucher for cash or redeem the voucher for store merchandise. | 10-01-2015 |
Arkady Fridman, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20130262213 | Systems, Methods, And Computer Program Products Providing Payment With Non-Traditional Sources Of Value - A system including a memory storing user account information, wherein the information comprises funding sources including multiple non-cash, non-credit based funding options; and one or more processors for communicating the multiple non-cash, non-credit based funding options on a merchant site; receiving a selection of a first option of the multiple non-cash, non-credit based funding options made by a user from the merchant site; and processing a payment using the selected first option. | 10-03-2013 |
Arthur Fridman, Secaucus, NJ US
Patent application number | Description | Published |
---|---|---|
20110182926 | MINIGENE - The present invention provides minigenes suitable as a prophylactic or therapeutic vaccine against conditions such as cancer, infectious diseases or autoimmune diseases, and pharmaceutical compositions comprising the minigene. The minigenes of the present invention comprise (a) a human tissue plasminogen signal peptide; (b) at least one T-cell epitope; and (c) an | 07-28-2011 |
Arthur Fridman, East Norriton, PA US
Patent application number | Description | Published |
---|---|---|
20140030287 | ENOLASE PEPTIDE CONJUGATE VACCINES AGAINST STAPHYLOCOCCUS AUREUS - The present invention relates to peptides of the enolase protein from | 01-30-2014 |
Boris Fridman, York, PA US
Patent application number | Description | Published |
---|---|---|
20130058719 | Mobile Asphalt Concrete Production Machine - A mobile asphalt production machine which includes support for different asphalt concrete recipes including a plurality of aggregate storage bins which work on combination with a fines or sands storage bin. The individual bins have separated feeding chutes to the mixing trough. The machinery also includes a removable pan at the elevator transfer station to accommodate changeover from one grade aggregate material to another. Further, a controller is provided which delivers appropriate ingredients while also measuring process parameters to adjust various input requirements. Further, a dust and particulate recapturing system is provided which recycles particulate matter back into the ribbon of mixed material with a binding agent. | 03-07-2013 |
20150125206 | Mobile Asphalt Concrete Production Machine - A mobile asphalt production machine which includes support for different asphalt concrete recipes including a plurality of aggregate storage bins which work on combination with a fines or sands storage bin. The individual bins have separated feeding chutes to the mixing trough. The machinery also includes a removable pan at the elevator transfer station to accommodate changeover from one grade aggregate material to another. Further, a controller is provided which delivers appropriate ingredients while also measuring process parameters to adjust various input requirements. Further, a dust and particulate recapturing system is provided which recycles particulate matter back into the ribbon of mixed material with a binding agent. | 05-07-2015 |
Dimitry Dany Fridman, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20160048398 | ENHANCING A MULTITASKING USER INTERFACE OF AN OPERATING SYSTEM - Techniques for enhancing a mufti-tasking user interface of an operating system are disclosed. An update data item pertaining to an application placed in the background on the device is received. An update image is generated to include information pertaining to the update data item. The update image is incorporated into a multitasking user interface of the operating system such that the update image is presented to a user and the user may view the information pertaining to the update data item before choosing whether to bring the application to the foreground. | 02-18-2016 |
Dmitriy Fridman, Naperville, IL US
Patent application number | Description | Published |
---|---|---|
20150288543 | ALGORITHMICALLY ADJUSTING THE NUMBER OF EQUALIZER TAPS IN AN UPSTREAM RECIEVER - Methods, systems, and computer readable media can be operable to dynamically determine an optimal number of equalizer taps to be used at an upstream receiver based upon existing conditions on an upstream channel. Pre-equalizer coefficients associated with an upstream channel can be used to determine an optimal number of equalizer taps to be used at an upstream receiver. The number of equalizer taps can be dynamically determined for an individual customer premise equipment device or for a plurality of customer premise equipment devices using the same upstream channel. | 10-08-2015 |
Dmitriy Fridman, Geneva, IL US
Patent application number | Description | Published |
---|---|---|
20090106331 | DYNAMIC TWO-STAGE CLINICAL DATA ARCHIVING AND RETRIEVAL SOLUTION - Certain embodiments of the present invention provide methods and systems for dynamic, two-stage archiving and/or retrieval of clinical data. Certain embodiments provide a method for dynamic, two-stage clinical data archiving. The method includes copying clinical data from a primary datastore to a staging datastore, wherein non-clinical data is retained at the primary datastore and not passed to the staging datastore. The method further includes copying the clinical data from the staging datastore to an archive datastore. The method also includes deleting the clinical data from the staging datastore after the clinical data has been copied to the archive datastore. In certain embodiments, data may be restored from the archive datastore to the primary datastore via the staging datastore similar to the archiving process described above. | 04-23-2009 |
Eyal Fridman, Ann Arbor, MI US
Patent application number | Description | Published |
---|---|---|
20110289632 | METHYLKETONE SYNTHASE, PRODUCTION OF METHYLKETONES IN PLANTS AND BACTERIA - Isolated genes and amino acid sequences encode methylketone synthase 2 (MKS2) enzymes from tomato plants, including, ShMKS2 and SlMKS2. When expressed recombinantly in bacteria and other host cells, the MKS2 enzymes produce methylketones of various carbon chain lengths ranging from C | 11-24-2011 |
Gene Fridman, Santa Clarita, CA US
Patent application number | Description | Published |
---|---|---|
20130096654 | Vestibular Implant System with Low Battery Alert - A vestibular implant system is described which includes an implantable vestibular stimulator providing a vestibular stimulation signal to electrically stimulate target neural tissue for vestibular sensation by a patient. A patient warning alarm process alters the stimulation signal when a given alarm condition occurs to change the vestibular sensation of the patient thereby warning the patient of the alarm condition. | 04-18-2013 |
Gene Fridman, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20130131761 | HIGH-VOLTAGE CMOS NEUROELECTRONIC INTERFACE FOR A MULTICHANNEL VESTIBULAR PROSTHESIS - A multichannel vestibular prosthesis includes a sensor system and a microcontroller configured to communicate with the sensor system to receive sensor signals from the sensor system while in operation. The microcontroller is configured to provide control signals in response to the sensor signals. The multichannel vestibular prosthesis also includes a neuroelectronic interface integrated circuit configured to communicate with the microcontroller to receive the control signals, and a plurality of electrodes electrically connected to the neuroelectronic interface integrated circuit. The neuroelectronic interface integrated circuit includes a digital controller configured to communicate with the microcontroller, a plurality of digital-to-analog converters configured to communicate with the digital controller, and a plurality of analog current control circuits, each constructed to communicate with a respective one of the plurality of digital-to-analog converters. Each of the plurality of analog current control circuits can be electrically connected directly or under software control to a respective one of a plurality of electrodes for delivering electrical stimuli to at least one vestibular nerve, and the digital controller is configured to control amplitudes, frequencies, polarities and durations of currents to be delivered to any combination of the plurality of electrical leads. | 05-23-2013 |
Gene Y. Fridman, Santa Clarita, CA US
Patent application number | Description | Published |
---|---|---|
20090187237 | Inner Hair Cell Stimulation Model for Use by a Cochlear Implant System - The stimulation provided in the electrically stimulated cochlea is modulated in accordance with the amplitude of a received acoustic signal and the onset of a sound in a received acoustic signal to provide increased sound perception. An onset time that corresponds to the onset of a sound is detected in an acoustic signal associated with a frequency band. A forcing voltage and a transmitting factor are determined, wherein the forcing voltage and the transmitting factor are associated with the frequency band at the detected onset time. The acoustic signal is modulated as a function of the forcing voltage and the transmitting factor to generate an output signal. The generated output signal can be used to stimulate the cochlea. The modulation strategy can be used in conjunction with sound processing strategies that employ frequency modulation, amplitude modulation, or a combination of frequency and amplitude modulation. | 07-23-2009 |
20100179616 | Outer Hair Cell Stimulation Model for the Use by an Intra-Cochlear Implant - Contrast between various frequency components of sound is enhanced through a lateral suppression strategy to provide increased speech perception in the electrically stimulated cochlea. A received audio signal is divided into a plurality of input signals, wherein each input signal is associated with a frequency band. A plurality of envelope signals are generated by determining the envelope of each of a plurality of the input signals. At least one of the envelope signals is scaled in accordance with a scaling factor to generate at least one scaled envelope signal. An output signal is generated by combining at least one envelope signal with at least one scaled envelope signal, and the cochlea is stimulated based on the generated output signal. The lateral suppression strategy can be applied to one or more frequency bands using scaled amplitude signals associated with one or more neighboring frequency bands. | 07-15-2010 |
20100234920 | Spectral Contrast Enhancement in a Cochlear Implant Speech Processor - Psychophysical tests are administered to cochlear implant (CI) users to determine a spectral modulation transfer function (SMTF), smallest detectable spectral contrast as a function of spectral modulation frequency, for each individual CI user. The determined SMTF for individual CI user is compared against a SMTF of a normal hearing person to determine the specific enhancements needed. A profile of spectral enhancement achievable with variation of filter parameters, sigma and maximum that best fits the needed enhancements for the individual CI user is selected. Based on the corresponding sigma and maximum selected, a sound processing strategy is adjusted to provide customized spectral contrast enhancement for the individual CI user. The sound processing strategy implemented includes an outer hair cell model. | 09-16-2010 |
20110319965 | Optimizing Pitch Allocation in a Cochlear Stimulation System - Optimizing pitch allocation in a cochlear stimulation system may include implanting an electrode array having a plurality of electrodes into the cochlea of a patient, where the electrode array has an associated implant fitting characteristic that defines a relationship between the implanted electrode array and audio frequencies, presenting sounds through the electrode array to the patient, receiving from the patient a selection of one of the sounds that most closely conforms to a single note, and determining a slope of the implant fitting characteristic of the electrode array based on the sound selected by the patient. Each sound may include a fundamental frequency and one or more harmonics. The optimization may also include changing a center frequency of a band pass filter associated with each electrode based on the determined slope. | 12-29-2011 |
Gene Y. Fridman, Valencia, CA US
Patent application number | Description | Published |
---|---|---|
20110166625 | Methods and Apparatus For Cochlear Implant Signal Processing - A cochlear implant processing strategy increases speech clarity and higher temporal performance. The strategy determines the power spectral component within each channel, and dynamically selects or de-selects the channels through which a stimulation pulse is provided as a function of whether the spectral power of the channel is high or low. “High” and “low” are estimated relative to a selected spectral power, for example. The selected spectral power can be estimated by signal average or mean, or by other criteria. Once a selection of the channels to stimulate has been made, the system can decide that only those channels are stimulated, and stimulation is removed from the other channels. The selected channels are the ones on which the spectral power is above the mean of all the available channels. Fewer channels are stimulated at any time and the contrast of the stimulation is enhanced. Also, the temporal resolution increases as the number of channels that must be stimulated on a given frame decreases. This way, the channels which are presented to the patient are fewer in number and contain more temporal information. | 07-07-2011 |
20110166626 | Methods and Apparatus For Cochlear Implant Signal Processing - A cochlear implant processing strategy increases speech clarity and higher temporal performance. The strategy determines the power spectral component within each channel, and dynamically selects or de-selects the channels through which a stimulation pulse is provided as a function of whether the spectral power of the channel is high or low. “High” and “low” are estimated relative to a selected spectral power, for example. The selected spectral power can be estimated by signal average or mean, or by other criteria. Once a selection of the channels to stimulate has been made, the system can decide that only those channels are stimulated, and stimulation is removed from the other channels. The selected channels are the ones on which the spectral power is above the mean of all the available channels. Fewer channels are stimulated at any time and the contrast of the stimulation is enhanced. Also, the temporal resolution increases as the number of channels that must be stimulated on a given frame decreases. This way, the channels which are presented to the patient are fewer in number and contain more temporal information. | 07-07-2011 |
Gene Y. Fridman, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20140031899 | METHODS AND APPARATUS FOR COCHLEAR IMPLANT SIGNAL PROCESSING - An exemplary speech processor configured to be used in a cochlear implant system includes signal processing circuitry that 1) separates an incoming audio signal into a plurality of channels, wherein each channel included in the plurality of channels includes a channel signal included in a plurality of channel signals and representing a portion of the audio signal, 2) selects one or more channel signals from the plurality of channel signals that have a spectral power that exceeds a predetermined threshold value, the selected one or more channel signals corresponding to one or more channels included in the plurality of channels, and 3) designates only the one or more channels that correspond to the selected one or more channel signals to be used for stimulation representative of the incoming audio signal. | 01-30-2014 |
20140043157 | AUTOMATED VEHICLE CRASH WARNING SYSTEM USING EXTERNAL LIGHTS - An automated vehicle crash warning system may include a lighting system configured to be attached to the outside of the vehicle; a vehicle crash detector configured to detect a crash of the vehicle; and a light controller configured to cause the lighting system to illuminate when a crash of the vehicle is detected by the vehicle crash detector. | 02-13-2014 |
20140081352 | Inner Hair Cell Stimulation Model for Use by a Cochlear Implant System - The stimulation provided in the electrically stimulated cochlea is modulated in accordance with the amplitude of a received acoustic signal and the onset of a sound in a received acoustic signal to provide increased sound perception. An onset time that corresponds to the onset of a sound is detected in an acoustic signal associated with a frequency band. A forcing voltage and a transmitting factor are determined, wherein the forcing voltage and the transmitting factor are associated with the frequency band at the detected onset time. The acoustic signal is modulated as a function of the forcing voltage and the transmitting factor to generate an output signal. The generated output signal can be used to stimulate the cochlea. The modulation strategy can be used in conjunction with sound processing strategies that employ frequency modulation, amplitude modulation, or a combination of frequency and amplitude modulation. | 03-20-2014 |
20140145842 | VEHICLE ACCELERATION COMMUNICATION SYSTEM USING LIGHTS - An acceleration communication system may communicate acceleration information about a transportation apparatus to one or more persons. A lighting system may be attached to the transportation apparatus. An acceleration detector may detect the direction of lateral acceleration of the transportation apparatus. A light controller may cause the lighting system to illuminate in a manner that indicates the direction of the lateral acceleration detected by the acceleration detector. | 05-29-2014 |
Gene Yevgeny Fridman, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20120277835 | IMPLANTABLE VESTIBULAR PROSTHESIS - An implantable nerve stimulation device has a sensor system, a data processor in communication with the sensor system, and a nerve stimulation system in communication with the data processor and constructed to provide electrical stimulation to at least one branch of at least one vestibulocochlear nerve. The nerve stimulation system includes an electrode array that has a first plurality of electrodes structured to be surgically implanted in electrical communication with a superior branch of the vestibular nerve, a second plurality of electrodes structured to be surgically implanted in electrical communication with a horizontal branch of the vestibular nerve, a third plurality of electrodes structured to be surgically implanted in electrical communication with a posterior branch of the vestibular nerve, and a common erus reference electrode structured to be surgically implanted into a common eras of the vestibular labyrinth. | 11-01-2012 |
20130253286 | Device and System for Sensing Medically Relevant Information from the Mouth - An intraoral multisensor device includes a mouthpiece, a plurality of sensors at least one of attached to or integrated with the mouthpiece, and a data communications unit configured to receive signals from the plurality of sensors. The mouthpiece has a form to permit stable arrangement at least partially within a person's mouth such that it can remain for hands-free sensing of a plurality of biological parameters. Also, an intraoral multisensor system includes an intraoral multisensor device and a data processing device adapted to communicate with the intraoral multisensor device. | 09-26-2013 |
20140364796 | Artifact Control and Miniaturization of the Safe Direct Current Stimulator for Neural Prostheses - An embodiment in accordance with the present invention provides a device and method to deliver direct ionic current safely to target neural tissue, while also eliminating interruptions in the output of the device that can result from the non-ideal operation of the valves used to control the current flow in the device. The device includes two valve-operated systems that work in tandem. The first and second current producing systems are configured to be used together in order to eliminate the periodic interruptions in current flow. In use, one system drives current through the target tissue, while the other system closes all of the valves first and then opens its valves in sequence. This intermediate step of closing all of the valves prevents unintended current shunts through either system. The device also includes two conductors to direct the flow of direct current into the target tissue. | 12-11-2014 |
Gene Yevgeny Fridman, Pikesville, MD US
Patent application number | Description | Published |
---|---|---|
20150039057 | IMPLANTABLE VESTIBULAR PROSTHESIS - An implantable nerve stimulation device has a sensor system, a data processor in communication with the sensor system, and a nerve stimulation system in communication with the data processor and constructed to provide electrical stimulation to at least one branch of at least one vestibulocochlear nerve. The nerve stimulation system includes an electrode array that has a first plurality of electrodes structured to be surgically implanted in electrical communication with a superior branch of the vestibular nerve, a second plurality of electrodes structured to be surgically implanted in electrical communication with a horizontal branch of the vestibular nerve, a third plurality of electrodes structured to be surgically implanted in electrical communication with a posterior branch of the vestibular nerve, and a common crus reference electrode structured to be surgically implanted into a common crus of the vestibular labyrinth. | 02-05-2015 |
20150209580 | IMPLANTABLE VESTIBULAR PROSTHESIS - An implantable nerve stimulation device has a sensor system, a data processor in communication with the sensor system, and a nerve stimulation system in communication with the data processor and constructed to provide electrical stimulation to at least one branch of at least one vestibulocochlear nerve. The nerve stimulation system includes an electrode array that has a first plurality of electrodes structured to be surgically implanted in electrical communication with a superior branch of the vestibular nerve, a second plurality of electrodes structured to be surgically implanted in electrical communication with a horizontal branch of the vestibular nerve, a third plurality of electrodes structured to be surgically implanted in electrical communication with a posterior branch of the vestibular nerve, and a common crus reference electrode structured to be surgically implanted into a common crus of the vestibular labyrinth. | 07-30-2015 |
Gideon Fridman, Fullerton, CA US
Patent application number | Description | Published |
---|---|---|
20100077584 | Bearing Remover - A bearing remover is configured to cooperate with a puller to remove a bearing from an axle. The bearing remover includes a claw that has an opening to receive a portion of the axle, and a lip that can be inserted between the bearing and the wall. The bearing remover also includes a centering component that fits about the axle. The claw and centering component are mechanically coupled to assist in maintaining the claw about the bearing, and to transmit a force to the claw. | 04-01-2010 |
Gregory Fridman, Marlton, NJ US
Patent application number | Description | Published |
---|---|---|
20090054896 | CONTROL OF MUCUS MEMBRANE BLEEDING WITH COLD PLASMA - The use of non-thermal plasma to treat mucus membrane bleeding is described herein. A non-thermal plasma is generated using an apparatus having a first electrode that receives alternating electrical potentials from a power supply. When placed in an appropriate location proximate to tissue, a non-thermal plasma is generated, the second electrode being human tissue, blood, etc. To reduce the likelihood of an arc being generated, potentially causing tissue damage or pain, the first electrode is partially encapsulated by a dielectric. The non-thermal plasma is applied to the area of bleeding for treatment. | 02-26-2009 |
Gregory Fridman, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20100145253 | METHODS FOR NON-THERMAL APPLICATION OF GAS PLASMA TO LIVING TISSUE - Method for the non-thermal treatment of human or animal tissue with high-voltage electrical discharge plasma is disclosed. The disclosed method employs current through plasma and through tissue not for the purpose of heating the tissue, but instead to maintain the plasma proximate to the tissue being treated. Also disclosed is a method of limiting the current through plasma and through tissue to minimize tissue heating by placement of an insulator or semiconductor between an electrode and tissue resulting in generation of a high-voltage discharge similar to a dielectric barrier discharge. The disclosed non-thermal plasma treatment can be employed to promote coagulation of blood, sterilization, disinfection, re-connection of tissue, and treatment of tissue disorders without causing significant thermal tissue damage. | 06-10-2010 |
20120100524 | TUBULAR FLOATING ELECTRODE DIELECTRIC BARRIER DISCHARGE FOR APPLICATIONS IN STERILIZATION AND TISSUE BONDING - Disclosed is a device and method for contacting a biological substrate. A non-thermal plasma device delivers a non-thermal plasma discharge using a dielectric conduit, an igniter electrode and a RF electrode. The dielectric conduit fluidicly communicates a gas therethrough and an igniter electrode ionizes at least a portion of the gas. The RF electrode, disposed circumferentially proximate to the exterior of the dielectric conduit, generates non-thermal plasma from the ionized gas. The non-thermal plasma is discharged from the dielectric conduit and contacts a biological substrate. The non-thermal plasma discharge may be suitable for tissue bonding and sterilization applications. | 04-26-2012 |
20120156091 | METHODS AND DEVICES FOR TREATING SURFACES WITH SURFACE PLASMA` - Methods and devices for treating surfaces of objects using a non-thermal plasma are disclosed herein. The non-thermal plasma is generated through the use of an apparatus configured to generate a non-thermal plasma on its surface. The apparatus is comprised of a substrate that contains one or more electrodes of different polarity. The electrodes are placed within a layer of the substrate acting as a dielectric layer. The apparatus may also have additional layers to contain the dielectric layer. When an appropriate potential, being either an alternating current or pulsed high voltage potential, is applied and removed from the one or more electrodes, the gas on at least one surface of the apparatus becomes ionized and forms a non-thermal plasma. The electrodes can be configured to be of various shapes and sizes to modify or tune the plasma. | 06-21-2012 |
20120253265 | METHODS AND DEVICES FOR THE TREATMENT AND PREVENTION OF MALIGNANCY IN ENTERIC DISEASES USING NON-THERMAL PLASMA - Non-thermal plasma is a partly ionized gas, which can be generated by a high-voltage electric field at a low pressure. Disclosed herein are apparatuses and methods for treating an enteric disease in vivo using non-thermal plasma. The disclosed apparatuses have a first conduit comprising a lumen and a tip; a first electrode disposed within the lumen of the first conduit; a second electrode comprised of a metal conduit disposed within the first conduit; an insulator disposed within the lumen of the first conduit, the insulator configured to electrically insulate the first electrode from the second electrode; and a gas channel disposed between the outer surface of the metal conduit and the inner surface of the first conduit, the gas channel being capable of feeding a gas from a gas source to the tip, wherein when the potential is applied, the gas is ionized to produce the non-thermal plasma. | 10-04-2012 |
20120296265 | APPARATUS FOR ATMOSPHERIC PRESSURE PIN-TO-HOLE SPARK DISCHARGE AND USES THEREOF - Disclosed herein are atmospheric pressure pin-to-hole pulsed spark discharge devices and methods for creating plasma. The devices include a conduit for fluidically communicating a gas, a plasma, or both, therethrough, portion of the conduit capable of being connected to a gas supply, and a second portion of the conduit capable of emitting a plasma; a positive electrode comprising a sharp tip; and a ground plate electrode. Disclosed are methods for treating a skin ulcer using non-thermal plasma include flowing a gas through a cold spark discharge zone simultaneously with the creation of a pulsed spark discharge to give rise to a non-thermal plasma emitted from a conduit, the non-thermal plasma comprising NO; and contacting a skin ulcer with said non-thermal plasma for sufficient time and intensity to give rise to treatment of the skin ulcer. | 11-22-2012 |
20130310731 | METHODS FOR NON-THERMAL APPLICATIONS OF GAS PLASMA TO LIVING TISSUE - Method for the non-thermal treatment of human or animal tissue with high-voltage electrical discharge plasma is disclosed. The disclosed method employs current through plasma and through tissue not for the purpose of heating the tissue, but instead to maintain the plasma proximate to the tissue being treated. Also disclosed is a method of limiting the current through plasma and through tissue to minimize tissue heating by placement of an insulator or semiconductor between an electrode and tissue resulting in generation of a high-voltage discharge similar to a dielectric barrier discharge. The disclosed non-thermal plasma treatment can be employed to promote coagulation of blood, sterilization, disinfection, re-connection of tissue, and treatment of tissue disorders without causing significant thermal tissue damage. | 11-21-2013 |
20130330229 | PLASMA SYSTEM FOR AIR STERILIZATION - A method for decontaminating bioaerosol with high concentrations of bacterial, viral, spore and other airborne microorganisms or biologic contaminants in flight at high flow rates. A plasma screen created across the flow of air contaminated with airborne biologic agents renders contaminants non-culturable within milliseconds. The technology may cooperate with heating, ventilation, and air conditioning (HVAC) systems. It may be particularly beneficial in preventing bioterrorism and the spread of toxic or infectious agents, containing airborne pandemic threats such as avian flu, sterilizing spaces such as hospitals, pharmaceutical plants and manufacturing facilities, treating exhaust ventilation streams, minimizing biological environmental pollutants in industrial settings, improving general air quality, preventing sick building syndrome. | 12-12-2013 |
20140311891 | TUBULAR FLOATING ELECTRODE DIELECTRIC BARRIER DISCHARGE FOR APPLICATIONS IN STERILIZATION AND TISSUE BONDING - Disclosed is a device and method for contacting a biological substrate. A non-thermal plasma device delivers a non-thermal plasma discharge using a dielectric conduit, an igniter electrode and a RF electrode. The dielectric conduit fluidicly communicates a gas therethrough and an igniter electrode ionizes at least a portion of the gas. The RF electrode, disposed circumferentially proximate to the exterior of the dielectric conduit, generates non-thermal plasma from the ionized gas. The non-thermal plasma is discharged from the dielectric conduit and contacts a biological substrate. The non-thermal plasma discharge may be suitable for tissue bonding and sterilization applications. | 10-23-2014 |
20140314621 | METHODS AND DEVICES FOR TREATING SURFACES WITH SURFACE PLASMA - Methods and devices for treating surfaces of objects using a non-thermal plasma are disclosed herein. The non-thermal plasma is generated through the use of an apparatus configured to generate a non-thermal plasma on its surface. The apparatus is comprised of a substrate that contains one or more electrodes of different polarity. The electrodes are placed within a layer of the substrate acting as a dielectric layer. The apparatus may also have additional layers to contain the dielectric layer. When an appropriate potential, being either an alternating current or pulsed high voltage potential, is applied and removed from the one or more electrodes, the gas on at least one surface of the apparatus becomes ionized and forms a non-thermal plasma. The electrodes can be configured to be of various shapes and sizes to modify or tune the plasma. | 10-23-2014 |
20150038584 | MATERIALS FOR DISINFECTION PRODUCED BY NON-THERMAL PLASMA - Aspects of the present subject matter are directed to a method comprising contacting an fluid, optionally containing an added organic material, with a non-thermal plasma to form a disinfection composition, wherein the disinfection composition is a liquid, and contacting a surface with the disinfection composition, wherein the surface is at least partially disinfected upon contact with the disinfection composition. Additional aspects of the present subject matter are directed to a method comprising forming a disinfection composition by contacting an organic material with a non-thermal plasma, wherein the disinfection composition is a liquid. A further aspect of the present subject matter is directed to a disinfection composition comprising an organic material contacted by a non-thermal plasma, wherein the disinfection composition is a liquid. | 02-05-2015 |
Jordan Fridman, Newark, DE US
Patent application number | Description | Published |
---|---|---|
20080226553 | Cell-Based Rna Interference and Related Methods and Compositions - This invention provides, among other things, methods for performing RNA interference in stem cells and methods for using stem cells in vivo. | 09-18-2008 |
20090217404 | Cell-based RNA interference and related methods and compositions - The invention provides, among other things, methods for performing RNA interference (RNAi) in stem cells (such as embryonic stem cells) and methods for using such stem cells in vivo. The invention also provides various animal models based on conditional/inducible, reversible, tissue-specific/spacial, and/or developmental stage-specific/temporal RNAi of certain target genes, which animal model may be useful for, e.g., drug target identification and/or validation. | 08-27-2009 |
20100186097 | CELL-BASED RNA INTERFERENCE AND RELATED METHODS AND COMPOSITIONS - The invention provides, among other things, methods for performing RNA interference in stem cells and methods for using the stem cells in vivo. | 07-22-2010 |
Jordan S. Fridman, Newark, DE US
Patent application number | Description | Published |
---|---|---|
20100113416 | JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES - Methods, kits, and compositions for treating dry eye disorders and other related eye diseases are provided, wherein the methods, kits, and compositions utilize a JAK inhibitor. | 05-06-2010 |
20110223210 | HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS - The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases. | 09-15-2011 |
20110224157 | HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS - The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases. | 09-15-2011 |
20120263676 | COMPOSITIONS, METHODS AND KITS RELATING TO HER-2 CLEAVAGE - The present invention relates to compositions, methods and kits based on the ADAM-mediated cleavage of Her-2. The present invention also relates to treatments for cancer, and in particular, breast cancer, by modulating the ADAM-mediated cleavage of Her-2. Further, the invention relates to compositions, methods and kits based on the surprising synergistic effect between inhibition of Her-2 cleavage by an ADAM and certain cytostatic (e.g., Herceptin) and cytotoxic (e.g., Taxol) compounds in, among other things, inhibiting tumor cell proliferation and inducing cell death. Additionally, the invention relates to novel variants of ADAM15, designated ADAM15 variant 1 and ADAM15 variant 2, now identified and isolated. | 10-18-2012 |
20120301464 | JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES - Methods, kits, and compositions for treating dry eye disorders and other related eye diseases are provided, wherein the methods, kits, and compositions utilize a JAK inhibitor. | 11-29-2012 |
20120329782 | AZEPINE INHIBITORS OF JANUS KINASES - The present invention provides compounds that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases. | 12-27-2012 |
20130137681 | HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS - The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases. | 05-30-2013 |
20140005210 | Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors | 01-02-2014 |
20140018374 | Heteroaryl Substituted Pyrrolo[2,3-B]Pyridines And Pyrrolo[2,3-B]Pyrimidines As Janus Kinase Inhibitors - The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases. | 01-16-2014 |
20140031344 | AZEPINE INHIBITORS OF JANUS KINASES - The present invention provides compounds that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases. | 01-30-2014 |
20150238492 | Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors - The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases. | 08-27-2015 |
Jordan S. Fridman, Neward, DE US
Patent application number | Description | Published |
---|---|---|
20100022522 | HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS - The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases. | 01-28-2010 |
Jose Fridman, Newton, MA US
Patent application number | Description | Published |
---|---|---|
20140059323 | SYSTEMS AND METHODS OF DATA EXTRACTION IN A VECTOR PROCESSOR - Systems and methods of data extraction in a vector processor are disclosed. In a particular embodiment a method of data extraction in a vector processor includes copying at least one data element to a source register of a permutation network. The method includes reordering multiple data elements of the source register, populating a destination register of the permutation network with the reordered data elements, and copying the reordered data elements from the destination register to a memory. | 02-27-2014 |
20140071869 | DYNAMIC POWER SCALING OF DIGITAL MODEMS - A system and method dynamically scale power consumed by the circuitry of an electronic device based on channel state and/or data rate. The electronic device then operates according to the power scaling. The scaling may be in accordance with an effective data rate, a number of multiple input multiple output (MIMO) layers, receiver type, a cell scenario, or a number of carriers. A number of MIMO layers can be predicted based on at least one of channel conditions or a channel quality index (CQI). | 03-13-2014 |
Jose Fridman, Waban, MA US
Patent application number | Description | Published |
---|---|---|
20140244967 | VECTOR REGISTER ADDRESSING AND FUNCTIONS BASED ON A SCALAR REGISTER DATA VALUE - Techniques are provided for executing a vector alignment instruction. A scalar register file in a first processor is configured to share one or more register values with a second processor, the one or more register values accessed from the scalar register file according to an Rt address specified, in a vector alignment instruction, wherein a start location is determined from one of the shared register values. An alignment circuit in the second processor is configured to align data identified between the start location within a beginning Vu register of a vector register file (VRF) and an end location of a last Vu register of the VRF according to the vector alignment instruction. A store circuit is configured to select the aligned data from the alignment circuit and store the aligned data in the vector register file according to an alignment store address specified by the vector alignment instruction. | 08-28-2014 |
20140258680 | PARALLEL DISPATCH OF COPROCESSOR INSTRUCTIONS IN A MULTI-THREAD PROCESSOR - Techniques are addressed for parallel dispatch of coprocessor and thread instructions to a coprocessor coupled to a threaded processor. A first packet of threaded processor instructions is accessed from an instruction fetch queue (IFQ) and a second packet of coprocessor instructions is accessed from the IFQ. The IFQ includes a plurality of thread queues that are each configured to store instructions associated with a specific thread of instructions. A dispatch circuit is configured to select the first packet of thread instructions from the IFQ and the second packet of coprocessor instructions from the IFQ and send the first packet to a threaded processor and the second packet to the coprocessor in parallel. A data port is configured to share data between the coprocessor and a register file in the threaded processor. Data port operations are accomplished without affecting operations on any thread executing on the threaded processor. | 09-11-2014 |
20140281368 | CYCLE SLICED VECTORS AND SLOT EXECUTION ON A SHARED DATAPATH - An example method for executing multiple instructions in one or more slots includes receiving a packet including multiple instructions and executing the multiple instructions in one or more slots in a time shared manner. Each slot is associated with an execution data path or a memory data path. An example method for executing at least one instruction in a plurality of phases includes receiving a packet including an instruction, splitting the instruction into a plurality of phases, and executing the instruction in the plurality of phases. | 09-18-2014 |
20140281421 | ARBITRARY SIZE TABLE LOOKUP AND PERMUTES WITH CROSSBAR - An example method of updating an output data vector includes identifying a data value vector including element data values. The method also includes identifying an address value vector including a set of elements. The method further includes applying a conditional operator to each element of the set of elements in the address value vector. The method also includes for each element data value in the data value vector, determining whether to update an output data vector based on applying the conditional operator. | 09-18-2014 |
Krista Fridman, Penfield, NY US
Patent application number | Description | Published |
---|---|---|
20100178317 | Lens Care Solutions with Hyaluronic Acid - A method of retaining hyaluronic acid on a surface of a contact lens. The method comprises providing a contact lens care solution comprising; | 07-15-2010 |
20110263717 | Ophthalmic Compositions with Biguanide and PEG-Glycerol Esters - Ophthalmic compositions that comprise 0.1 ppm to 2 ppm of poly(hexamethylene biguanide); and 0.005 wt. % to 0.3 wt. % of a PEG-glycerol ester of general formula I | 10-27-2011 |
20130261190 | Ophthalmic Compositions with Biguanide and PEG-Glycerol Esters - Ophthalmic compositions comprising 0.5 ppm to 5 ppm of alexidine, and 0.005 wt. % to 0.3 wt. % of glycereth-18-ethylhexanoate. The invention is also directed to the use of the ophthalmic compositions to clean and disinfect contact lenses, and in particular, soft, silicone, hydrogel contact lenses. | 10-03-2013 |
20140206764 | Poly(Nitrogen/Amine) Derivatives of a Natural Wax and Ophthalmic Compositions - A poly(nitrogen/amine) derivative of a natural wax of formula I, and ophthalmic compositions and contact lens care solutions that contain the poly(nitrogen/amine) derivative of a natural wax of formula I. The invention is also directed to a method of treating a patient with dry eyes, the method comprising instructing a patient to administer one or more eye drops of the ophthalmic composition that includes a poly(nitrogen/amine) derivative of a natural wax of formula I. | 07-24-2014 |
20150297511 | OPHTHALMIC COMPOSITIONS WITH ALKOXYLATED NATURAL WAXES - Ophthalmic compositions comprising 0.005 wt. % to 2.0 wt. % of alkoxylated natural waxes selected from the group consisting of alkoxylated lanolin and alkoxylated jojoba, and a method of treating a patient diagnosed with dry eye syndrome, or for cleaning and disinfecting contact lenses, with the ophthalmic compositions. | 10-22-2015 |
Moses Alexander Fridman, Birmingham, MI US
Patent application number | Description | Published |
---|---|---|
20110295468 | Control Of A Vehicle Powertrain In Response To Brake Pedal Input - In the event that the brake pedal and accelerator pedal are depressed simultaneously, powertrain output is decreased monotonically with brake pedal input. In a lower range of brake pedal input, the brakes are prevented from actuating or are allowed to actuate minimally. In a higher range of pedal input, the powertrain output continues to be decreased and the brakes are allowed to actuate. In yet another higher range of pedal input, the powertrain output is substantially decreased such that a minimal powertrain output is achieved. The powertrain may include an internal combustion engine and/or an electric motor. The brake pedal input is determined based on a sensor associated with the brake pedal, the brake booster, or the master cylinder. | 12-01-2011 |
20120116656 | Vacuum Boost For Vehicle Braking - Power brakes are typically vacuum assisted, with the vacuum provided from the intake manifold. If the engine is commanded to operate for a long period at a condition with low intake manifold vacuum, the vacuum within the brake booster may drop to a level which is marginal or insufficient for a present or subsequent braking operation. To ensure sufficient vacuum in the intake manifold to provide to the brake booster, the engine may be commanded to operate at a condition to increase intake manifold vacuum by one of: adjusting cam timing, increasing engine speed, and increasing EGR. In the case of a stop-start vehicle, the engine speed is increased from zero to a condition that provides the desired vacuum. | 05-10-2012 |
20120237367 | Method and System for Providing Vacuum - A vacuum source arbitration system is disclosed. In one example, vacuum is supplied to a vacuum reservoir via an ejector during a first condition, and vacuum is supplied to the vacuum reservoir via an engine intake manifold during a second condition. The approach may provide a desired level of vacuum in a reservoir while reducing engine fuel consumption. | 09-20-2012 |
20130113270 | METHOD AND SYSTEM FOR BRAKE CONTROL - Methods and systems are provided to reduce a hard brake pedal feel. A brake control variable is adjusted in anticipation of a hard pedal condition to increase hydraulic brake line pressure and maintain a normal pedal feel. A pedal force is inferred from brake line pressure relative to brake booster vacuum. | 05-09-2013 |
Moses Alexander Fridman, West Bloomfield, MI US
Patent application number | Description | Published |
---|---|---|
20140102086 | METHOD AND SYSTEM FOR BRAKE CONTROL - Methods and systems are provided to reduce a hard brake pedal feel. A brake control variable is adjusted in anticipation of a hard pedal condition to increase hydraulic brake line pressure and maintain a normal pedal feel. A pedal force is inferred from brake line pressure relative to brake booster vacuum. | 04-17-2014 |
20140130775 | METHOD AND SYSTEM FOR PROVIDING VACUUM - A vacuum source arbitration system is disclosed. In one example, vacuum is supplied to a vacuum reservoir via an ejector during a first condition, and vacuum is supplied to the vacuum reservoir via an engine intake manifold during a second condition. The approach may provide a desired level of vacuum in a reservoir while reducing engine fuel consumption. | 05-15-2014 |
Natalio Fridman, New York, NY US
Patent application number | Description | Published |
---|---|---|
20140143761 | METHOD AND SYSTEM FOR DATABASE CONVERSION - A system and method for converting legacy program code to up to date program code is provided. The system and method includes a compiler having four modules—a parser, a transformer, an optimizer, and a code generator. The parser reads the code and analyzes the code by identifying key words, identifying key contextual indicators, and identifying inefficiencies in the code. The transformer translates the legacy program code to the up to date program code using a translation table. The optimizer reduces inefficiencies in the transformed code. | 05-22-2014 |
Rafael Fridman, West Bloomfield, MI US
Patent application number | Description | Published |
---|---|---|
20090005420 | Inhibitors of Matrix Metallaproteinases - The present invention provides novel compounds of formulas I-IX, as described herein. Also provided are compositions of compounds of formulas I-IX, methods of making compounds of formulas I-IX, and methods of using compounds of formulas I-IX. The compounds of the invention can be used to inhibit matrix metalloproteinases, and are useful to treat conditions and diseases associated therewith. | 01-01-2009 |
20090269779 | Galectin-3 cleavage as a marker for matrix metalloproteinase activity in cancer - Provided are differential antibodies recognizing the cleaved and non-cleaved forms of matrix metalloproteinases (MMPs), and methods of using the antibodies as surrogate diagnostic markers for the presence of active MMPs in cancer, such as growing breast cancers. | 10-29-2009 |
20110224275 | INHIBITORS OF MATRIX METALLOPROTEINASES - The present invention provides novel compounds of formulas I-IX, as described herein. Also provided are compositions of compounds of formulas I-IX, methods of making compounds of formulas I-IX, and methods of using compounds of formulas I-IX. The compounds of the invention can be used to inhibit matrix metalloproteinases, and are useful to treat conditions and diseases associated therewith. | 09-15-2011 |
Ron Fridman, Paoli, PA US
Patent application number | Description | Published |
---|---|---|
20110117867 | RECEIVED SIGNAL STRENGTH INDICATOR APPARATUS AND METHOD - Received signal strength indicator apparatus and methods are disclosed. A received signal strength indicator includes a modem, a display, a processor, and a step-up converter. The modem is configured to receive a signal. The processor is coupled to the modem and the display. The processor is configured to determine a strength of the signal and to indicate the strength of the signal on the display. The step-up converter is coupled to one of the modem, the processor, and the display. The step-up converter is configured to step-up the voltage of a power source to power the one of the modem, the processor, and the display. The received signal strength indicator is usable for determining a location for installing a vending machine. The location for installing the vending machine is selected based on the strength of the received signal. | 05-19-2011 |
20120191612 | PORTABLE E-WALLET AND UNIVERSAL CARD - Universal cards are used in place of all the other traditional cards which a person may want to carry. The universal card can include a short range communications transceiver to communicate with a mobile device. The mobile device can include a user interface and an e-wallet application so that the user can interface with the e-wallet application for programming the universal card via the short range communication link. Once programmed, the universal card emulates a function of a traditional card. | 07-26-2012 |
20130024372 | PORTABLE E-WALLET AND UNIVERSAL CARD - Universal cards are used in place of all the other traditional cards which a person may want to carry. The universal card can include a short range communications transceiver to communicate with a mobile device. The mobile device can include a user interface and an e-wallet application so that the user can interface with the e-wallet application for programming the universal card via the short range communication link. Once programmed, the universal card emulates a function of a traditional card. | 01-24-2013 |
20130030997 | PORTABLE E-WALLET AND UNIVERSAL CARD - Universal cards are used in place of all the other traditional cards which a person may want to carry. The universal card can include a short range communications transceiver to communicate with a mobile device. The mobile device can include a user interface and an e-wallet application so that the user can interface with the e-wallet application for programming the universal card via the short range communication link. Once programmed, the universal card emulates a function of a traditional card. | 01-31-2013 |
20130134216 | PORTABLE E-WALLET AND UNIVERSAL CARD - Universal cards are used in place of all the other traditional cards which a person may want to carry. The universal card can include a short range communications transceiver to communicate with a mobile device. The mobile device can include a user interface and an e-wallet application so that the user can interface with the e-wallet application for programming the universal card via the short range communication link. Once programmed, the universal card emulates a function of a traditional card. | 05-30-2013 |
20130200999 | PORTABLE E-WALLET AND UNIVERSAL CARD - Universal cards are used in place of all the other traditional cards which a person may want to carry. The universal card can include a short range communications transceiver to communicate with a mobile device. The mobile device can include a user interface and an e-wallet application so that the user can interface with the e-wallet application for programming the universal card via the short range communication link. Once programmed, the universal card emulates a function of a traditional card. | 08-08-2013 |
20140136417 | PORTABLE E-WALLET AND UNIVERSAL CARD - Universal cards are used in place of all the other traditional cards which a person may want to carry. The universal card can include a short range communications transceiver to communicate with a mobile device. The mobile device can include a user interface and an e-wallet application so that the user can interface with the e-wallet application for programming the universal card via the short range communication link. Once programmed, the universal card emulates a function of a traditional card. | 05-15-2014 |
20150379283 | PORTABLE E-WALLET AND UNIVERSAL CARD - Universal cards are used in place of all the other traditional cards which a person may want to carry. The universal card can include a short range communications transceiver to communicate with a mobile device. The mobile device can include a user interface and an e-wallet application so that the user can interface with the e-wallet application for programming the universal card via the short range communication link. Once programmed, the universal card emulates a function of a traditional card. | 12-31-2015 |
Vitali Fridman, Belmont, CA US
Patent application number | Description | Published |
---|---|---|
20090300770 | MECHANISM TO SEARCH INFORMATION CONTENT FOR PRESELECTED DATA - A method and apparatus for detecting preselected data embedded in information content is described. In one embodiment, the method comprises receiving information content and detecting in the information content a sequence of content fragments that may contain a portion of preselected data. The method further comprises determining whether a sub-set of these content fragments matches any sub-set of the preselected data using an abstract data structure that defines a tabular structure of the preselected data. | 12-03-2009 |
Vitall A. Fridman, Belmont, CA US
Patent application number | Description | Published |
---|---|---|
20120016884 | PERSONAL COMPUTING DEVICE-BASED MECHANISM TO DETECT PRESELECTED DATA - A method and apparatus for detecting pre-selected data stored on a personal computing device is described. In one embodiment, contents of data storage media of a personal computing device are searched for pre-selected sensitive data. In one embodiment, if at least a portion of the pre-selected sensitive data is detected, a notification of the detection of the pre-selected data is sent to a system via a network. In another embodiment, if at least a portion of pre-selected sensitive data is detected, the access to this data is blocked. | 01-19-2012 |
Vladimir Fridman, Louisville, KY US
Patent application number | Description | Published |
---|---|---|
20100010280 | CATALYST FOR DEHYDROGENATION OF HYDROCARBONS - A stationary or fluid bed dehydrogenation catalyst containing an alumina carrier, with chromium and alkali metals consisting of only sodium and potassium, added as promoters. The resultant catalyst demonstrates greater selectivity and olefin yield than prior art dehydrogenation catalysts, especially after aging. | 01-14-2010 |
20110251448 | ENDOTHERMIC HYDROCARBON CONVERSION PROCESS - The present invention is an improved cyclic, endothermic hydrocarbon conversion process and a catalyst bed system for accomplishing the same. Specifically, the improved process comprises reacting a hydrocarbon with a multi-component catalyst bed in such a manner that the temperature within the catalyst bed remains within controlled temperature ranges throughout all stages of the process. The multi-component catalyst bed comprises a reaction-specific catalyst physically mixed with a heat-generating material. | 10-13-2011 |
20140273794 | METHOD OF SHUTTING DOWN A REACTOR - A procedure for shutting down a dehydrogenation reactor having a catalyst bed with a chromium-containing catalyst operating at a first elevated temperature comprises cooling the catalyst bed with a first cooling gas to a second elevated temperature lower than the first elevated temperature, removing the first cooling gas, introducing a reducing gas to the catalyst bed, cooling the catalyst bed with a second cooling gas from the second elevated temperature to a third elevated temperature, removing the reducing gas, cooling the catalyst bed to a fourth elevated temperature, and introducing air to cool the catalyst to ambient temperature, whereby the dehydrogenation reactor is shut down. The second cooling gas may be the same as, or different from, the reducing gas. Moreover, the reducing gas may be purged from the reactor by a third cooling gas. | 09-18-2014 |
20150259265 | DEHYDROGENATION PROCESS WITH HEAT GENERATING MATERIAL - The disclosure provides an improved endothermic hydrocarbon conversion process that comprises reacting a hydrocarbon with a multi-component catalyst bed, and regenerating the catalyst bed with air, where the air used in regeneration step and hydrocarbon are at low air to hydrocarbon ratios and optionally at near-atmospheric pressures. | 09-17-2015 |
Vladimir Fridman, Bellevue, WA US
Patent application number | Description | Published |
---|---|---|
20090077043 | SYSTEM AND METHOD FOR ACCESSING NON-COMPATIBLE CONTENT REPOSITORIES - Systems and methods access non-compatible content repositories that are not natively accessible to a content management system. A metadata registry maintains metadata about content stored in both compatible and non-compatible repositories. For content in a non-compatible repository, the metadata indicates a repository interface capable of accessing the non-compatible repository. The content manager communicates with the repository interfaces to access the content in non-compatible repositories. The content manager may receive a request for content in a non-compatible repository, refer to the metadata registry to select a repository interface to employ, transmit a request for the requested content to the selected repository interface, and receive the requested content from the repository interface. A repository interface registry maintains information about available repository interfaces. Entries may be added to either the metadata registry and the repository interface registry, thus allowing the systems and methods to be extended to be able to access additional non-compatible repositories. | 03-19-2009 |
Vladimir Fridman, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20140280530 | Live Faces - In one embodiment, a method includes providing for presentation on a graphical user interface an identification of a user; and providing presence information of the user with the identification of the user. The presence information indicates a temporal, spatial, modal, or social accessibility or availability of user. The presence information includes real-time video of the user captured and is provided as presence information automatically and without user input of the user. | 09-18-2014 |
Vladlen Fridman, Naugatuck, CT US
Patent application number | Description | Published |
---|---|---|
20130305963 | Method of producing activated construction mixture - In a method of producing an activated construction mixture including cement, water, additives and superplasticizer the activation is performed with dimensionless criteria Reynolds and Power numbers within the limits of 20-800 and 4.0-0.1 respectively for increasing water adsorption with calcium silicate hydrate colloid formation and accelerating cement hydration. | 11-21-2013 |
Yuri Fridman, Glenview, IL US
Patent application number | Description | Published |
---|---|---|
20090325499 | THRESHOLD SELECTION FOR BROADCAST SIGNAL DETECTION | 12-31-2009 |